Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    August 2018
  1. FLEMING ND, Nick AM, Coleman RL, Westin SN, et al
    Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer.
    Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002796.
    PubMed     Text format     Abstract available


  2. FILIPPOVA OT, Chi DS
    The Unyielding Fight Against the Premature Death of Patients With Advanced-Stage Ovarian Cancer.
    Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002883.
    PubMed     Text format    


    June 2018
  3. UPPAL S, Spencer RJ, Rice LW, Del Carmen MG, et al
    Hospital Readmission as a Poor Measure of Quality in Ovarian Cancer Surgery.
    Obstet Gynecol. 2018 Jun 6. doi: 10.1097/AOG.0000000000002693.
    PubMed     Text format     Abstract available


    April 2018
  4. MENON U, Karpinskyj C, Gentry-Maharaj A
    Ovarian Cancer Prevention and Screening.
    Obstet Gynecol. 2018 Apr 6. doi: 10.1097/AOG.0000000000002580.
    PubMed     Text format     Abstract available


    November 2017
  5. BERCOW AS, Chen L, Chatterjee S, Tergas AI, et al
    Cost of Care for the Initial Management of Ovarian Cancer.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002317.
    PubMed     Text format     Abstract available


  6. PASCUAL MA, Graupera B, Pedrero C, Rodriguez I, et al
    Long-term Results for Expectant Management of Ultrasonographically Diagnosed Benign Ovarian Teratomas.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002327.
    PubMed     Text format     Abstract available


    October 2017
  7. DILLEY SE, Straughn JM Jr, Leath CA 3rd
    The Evolution of and Evidence for Opportunistic Salpingectomy.
    Obstet Gynecol. 2017;130:814-824.
    PubMed     Text format     Abstract available


    September 2017
  8. LIPPITT MH, Fairbairn MG, Matsuno R, Stone RL, et al
    Outcomes Associated With a Five-Point Surgical Site Infection Prevention Bundle in Women Undergoing Surgery for Ovarian Cancer.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002213.
    PubMed     Text format     Abstract available


  9. VISSER NCM, Reijnen C, Massuger LFAG, Nagtegaal ID, et al
    Accuracy of Endometrial Sampling in Endometrial Carcinoma: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002261.
    PubMed     Text format     Abstract available



  10. Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.
    Obstet Gynecol. 2017;130:e146-e149.
    PubMed     Text format     Abstract available



  11. Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome.
    Obstet Gynecol. 2017;130:e110-e126.
    PubMed     Text format     Abstract available



  12. Committee Opinion No. 716 Summary: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.
    Obstet Gynecol. 2017;130:664-665.
    PubMed     Text format     Abstract available



  13. Practice Bulletin No. 182 Summary: Hereditary Breast and Ovarian Cancer Syndrome.
    Obstet Gynecol. 2017;130:657-659.
    PubMed     Text format     Abstract available


    August 2017
  14. WRIGHT JD, Chen L, Hou JY, Burke WM, et al
    Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer.
    Obstet Gynecol. 2017 Aug 4. doi: 10.1097/AOG.0000000000002164.
    PubMed     Text format     Abstract available


  15. MARTINELLI F, Ditto A, Bogani G, Raspagliesi F, et al
    Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy.
    Obstet Gynecol. 2017;130:469-470.
    PubMed     Text format    


    July 2017
  16. SPENCER RJ, Hacker KE, Griggs JJ, Rice LW, et al
    Ninety-Day Mortality as a Reporting Parameter for High-Grade Serous Ovarian Cancer Cytoreduction Surgery.
    Obstet Gynecol. 2017 Jul 7. doi: 10.1097/AOG.0000000000002140.
    PubMed     Text format     Abstract available


  17. MATSUO K, Machida H, Stone RL, Soliman PT, et al
    Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer.
    Obstet Gynecol. 2017 Jul 7. doi: 10.1097/AOG.0000000000002142.
    PubMed     Text format     Abstract available


  18. CORY L, Latif N, Brensinger C, Zhang X, et al
    Readmission After Gynecologic Surgery: A Comparison of Procedures for Benign and Malignant Indications.
    Obstet Gynecol. 2017 Jul 7. doi: 10.1097/AOG.0000000000002141.
    PubMed     Text format     Abstract available


    June 2017
  19. MELAMED A, Rizzo AE, Nitecki R, Gockley AA, et al
    All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002102.
    PubMed     Text format     Abstract available


    May 2017
  20. BAKKUM-GAMEZ JN, Dowdy SC
    Venous Thromboembolism: An Unrecognized Crisis in Gynecologic Oncology.
    Obstet Gynecol. 2017 May 8. doi: 10.1097/AOG.0000000000002073.
    PubMed     Text format    


  21. GRECO PS, Bazzi AA, McLean K, Reynolds RK, et al
    Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy.
    Obstet Gynecol. 2017 May 5. doi: 10.1097/AOG.0000000000001980.
    PubMed     Text format     Abstract available


  22. FAJAU-PREVOT C, Le Gac YT, Chevreau C, Cohade C, et al
    Ovarian Mucinous Cystadenoma After Ovarian Graft.
    Obstet Gynecol. 2017 May 5. doi: 10.1097/AOG.0000000000001990.
    PubMed     Text format     Abstract available


    April 2017
  23. MELAMED A, Nitecki R, Boruta DM 2nd, Del Carmen MG, et al
    Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000001851.
    PubMed     Text format     Abstract available


    February 2017
  24. GOCKLEY A, Melamed A, Bregar AJ, Clemmer JT, et al
    Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer.
    Obstet Gynecol. 2017 Feb 6. doi: 10.1097/AOG.0000000000001867.
    PubMed     Text format     Abstract available


    September 2016
  25. MATSUO K, Machida H, Shoupe D, Melamed A, et al
    Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  26. EVANS EC, Matteson KA, Orejuela FJ, Alperin M, et al
    Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  27. WRIGHT JD, Hou JY, Burke WM, Tergas AI, et al
    Utilization and Toxicity of Alternative Delivery Methods of Adjuvant Chemotherapy for Ovarian Cancer.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  28. CHATTERJEE S, Chen L, Tergas AI, Burke WM, et al
    Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  29. MOTOHARA T, Fujimoto K, Tayama S, Narantuya D, et al
    CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  30. HARMSEN MG, IntHout J, Arts-de Jong M, Hoogerbrugge N, et al
    Salpingectomy With Delayed Oophorectomy in BRCA1/2 Mutation Carriers: Estimating Ovarian Cancer Risk.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  31. CHAPPELL NP, Miller C, Barnett J, Fielden A, et al
    Is FDA Approved Bevacizumab Cost-Effective in the Setting of Platinum-Resistant Recurrent Ovarian Cancer? [18].
    Obstet Gynecol. 2016;127 Suppl 1:6S-7S.
    PubMed     Text format     Abstract available


  32. GOTIMER KF, Bondoc C, Chalas E, Villella JA, et al
    Self Reported Quality of Life Among Patients Who Have Undergone Outpatient IP Chemotherapy for Ovarian Cancer [11].
    Obstet Gynecol. 2016;127 Suppl 1:4S.
    PubMed     Text format     Abstract available


    April 2016
  33. POWER L, Lefas G, Lambert P, Kim D, et al
    Hormone Use After Nonserous Epithelial Ovarian Cancer: Overall and Disease-Free Survival.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  34. SCHORGE JO
    What Is New in Prevention of Ovarian Cancer?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  35. WRIGHT JD, Tergas AI, Hou JY, Burke WM, et al
    Trends in Periodic Surveillance Testing for Early-Stage Uterine Cancer Survivors.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  36. LIN JJ, Egorova N, Franco R, Prasad-Hayes M, et al
    Ovarian Cancer Treatment and Survival Trends Among Women Older Than 65 Years of Age in the United States, 1995-2008.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  37. WRIGHT JD, Huang Y, Burke WM, Tergas AI, et al
    Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  38. WRIGHT JD, Jorge S, Tergas AI, Hou JY, et al
    Utilization and Outcomes of Ovarian Conservation in Premenopausal Women With Endometrial Cancer.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  39. BARBER EL, Boggess JF, Van Le L, Kim KH, et al
    Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian Cancer.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  40. ESSELEN KM, Vitonis A, Einarsson J, Muto MG, et al
    Health Care Disparities in Hysterectomy for Gynecologic Cancers: Data From the 2012 National Inpatient Sample.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  41. TEMKIN SM, Terplan M
    Trends in Relative Survival for Ovarian Cancer From 1975-2011.
    Obstet Gynecol. 2015;126:898.
    PubMed     Text format    


  42. WRIGHT JD, Chen L, Hershman DL
    In Reply.
    Obstet Gynecol. 2015;126:898-9.
    PubMed     Text format    


    September 2015
  43. MELAMED A, Rauh-Hain JA, Clemmer JT, Diver EJ, et al
    Changing Trends in Lymphadenectomy for Endometrioid Adenocarcinoma of the Endometrium.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  44. CRESS RD, Chen YS, Morris CR, Petersen M, et al
    Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  45. PRAT J
    Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum: Abridged Republication of Guidelines From the International Federation of Gynecology and Obstetrics (FIGO).
    Obstet Gynecol. 2015;126:171-4.
    PubMed     Text format    


    June 2015
  46. WRIGHT JD, Chen L, Tergas AI, Patankar S, et al
    Trends in relative survival for ovarian cancer from 1975 to 2011.
    Obstet Gynecol. 2015;125:1345-52.
    PubMed     Text format     Abstract available


  47. RAUH-HAIN JA, Hariton E, Clemmer J, Clark RM, et al
    Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer.
    Obstet Gynecol. 2015;125:1362-70.
    PubMed     Text format     Abstract available


    April 2015
  48. YEH KE, Marcus PS, Fong TL
    Paraneoplastic Cholestasis Associated With Ovarian Dysgerminoma.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


    January 2015
  49. JANCO JM, Gloviczki P, Friese JL, Cliby WA, et al
    Lymphatic Mapping and Ligation for Persistent Ascites After Surgery for Gynecologic Malignancy.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: